Common scenarios facing pulmonologists and rheumatologists are addressed using the current best evidence.
Find out how potential clinical biomarkers for COPD could be used to personalize treatment and lead to improved disease management.
Has the genetic hot-spot for predicting therapeutic response to inhaled corticosteroids been discovered?
Don't miss this literature review of influenza-related neurological complications related to the influenza A (H1N1) pandemic of 2009.
LTRAs are the first new approach in asthma therapy in the past 25 years and the first class of drugs to target components of the inflammatory process.
Get clear on diagnostic criteria for acute interstitial pneumonia and learn to identify what to exclude before making the diagnosis.
Does urinary albumin creatinine ratio reflect glomerular damage related to aortic stiffness?
Best practices for ICU patients are reviewed.
The effectiveness of hand hygiene to prevent the transmission of influenza may vary based on the community setting.
A new international statement defines usual interstitial pneumonia -- in a more precise way than before. . .
What actions are being taken to overcome the COPD care-bundle hurdles?
Find out how changes in the new GOLD classification for chronic obstructive pulmonary disease have impacted patient care. What's next?
Can saliva testing help COPD patients stay healthier?
Can aerosolized antibiotics deliver effective local drug concentrations to the infection site and decrease the risk of systemic side effects associated with oral or intravenous antibiotics?
Get evidence based clinical recommendations about airway clearance techniques -- for patients with chronic obstructive pulmonary disease.
Learn more about current thinking regarding COPD and find out how three different mechanisms of airflow obstruction play a role in COPD pathogenesis.
Erdosteine decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and a scavenging effect on free oxidant radicals.
Epidemiological data indicate that low levels of vitamin D are associated with increased incidence of inflammatory or neoplastic disease. This study takes a closer look.